About Miconazole Nitrate IP
Since establishment in the year 1980, we have been engrossed in providing top grade Miconazole Nitrate IP. This intermediate is processed using quality-examined chemical compounds and cutting-edge methodology at modern processing unit. Offered intermediate is widely used to treat vaginal yeast infections and external vulvar itching associated with yeast infection. In addition to this, our clients can get this Miconazole Nitrate IP at pocket friendly prices in varied packaging options.
Features:
- Non hazardous
- Balanced composition
- Standard shelf life
- Free from impurity
Pharmaceutical Grade Antifungal AgentMiconazole Nitrate IP serves as a trusted antifungal ingredient in a broad range of pharmaceutical formulations. With a molecular weight of 479.14 g/mol and a chemical structure that ensures potent antifungal activity, it is suitable for various delivery modes. Its stable, crystalline powder form guarantees efficiency and consistency in manufactural processes.
Quality Standards and PurityThis product strictly follows Indian Pharmacopoeia (IP), British Pharmacopoeia (BP), and United States Pharmacopoeia (USP) standards. It contains not less than 99% purity, and tightly adheres to regulations concerning impurities, heavy metals, and moisture content, ensuring maximum safety and therapeutic benefit during use.
Packaging and Storage SolutionsPackaged in HDPE drums or double polyethylene bags, Miconazole Nitrate IP is safeguarded from environmental moisture and light. Proper storage at room temperature in tightly closed containers guarantees a shelf life of up to five years, maintaining its efficacy and stability for pharmaceutical production and distribution.
FAQs of Miconazole Nitrate IP:
Q: How is Miconazole Nitrate IP typically used in pharmaceutical applications?
A: Miconazole Nitrate IP is commonly used for its antifungal properties in topical creams, oral suspensions, and parenteral preparations. Its efficacy makes it suitable for treating a variety of fungal infections in pharmaceutical formulations.
Q: What benefits does Miconazole Nitrate IP offer over other antifungal agents?
A: This compound provides reliable antifungal activity, high purity (minimum 99%), and compliance with multiple pharmacopeial standards (IP, BP, USP). These features ensure consistent results and safety in pharmaceutical applications.
Q: When should Miconazole Nitrate IP be stored and under what conditions?
A: Miconazole Nitrate IP should always be stored in tightly closed containers, protected from light and moisture, at room temperature. Proper storage maintains its stability and extends its shelf life to five years.
Q: Where can Miconazole Nitrate IP be sourced, and who are the primary users?
A: It can be sourced from manufacturers, distributors, suppliers, exporters, and traders in India. The primary users are pharmaceutical companies involved in antifungal product development and production.
Q: What is the standard process for identifying Miconazole Nitrate IP?
A: Identification is confirmed by a positive reaction to Miconazole Nitrate, as outlined in pharmacopeial methods, ensuring it meets the expected molecular characteristics and composition.
Q: How does the packaging of Miconazole Nitrate IP ensure its quality during transportation and storage?
A: The material is sealed in HDPE drums or double polyethylene bags, which provide robust protection against moisture, contamination, and physical damage, preserving quality and purity until point of use.
Q: What are the recommended uses and modes of administration for Miconazole Nitrate IP?
A: This antifungal agent is recommended for topical, oral, and parenteral administration, making it versatile for treating various fungal conditions as prescribed in pharmaceutical formulations.